Skip to content

Anna Stankiewicz

Department of Psychiatry, Medical University of Białystok, Poland.

2 papers in the library · 6 citations · publishing 2024-2025

Papers

Side effects of microdosing lysergic acid diethylamide and psilocybin: A systematic review of potential physiological and psychiatric outcomes

Neuropharmacology March 7, 2025 Stefan Modzelewski, Anna Stankiewicz, Napoleon Waszkiewicz et al. 5 citations

A review of psychedelic research finds that studies vary widely in how they report side effects and often follow participants for only a short time. The authors call for future work to describe side effects more clearly and systematically. This limitation makes it difficult to fully understand the risks associated with substances like psilocybin and LSD.

Potencjał terapeutyczny wybranych substancji psychoaktywnych — przegląd najnowszych badań

Psychiatria June 5, 2024 Anna Stankiewicz, Jan Szewczyk, Julia Truszkowska et al. 1 citation

Since 2019, research on psychedelics including LSD, MDMA, psilocybin, and THC, as well as less-studied substances like 5-MeO-DMT, dextromethorphan, DMT, ibogaine, ketamine, and mescaline, indicates therapeutic potential for treating addiction (nicotine, alcohol, and substance dependence), depression, anxiety (including anxiety in autism spectrum disorder), PTSD, and eating disorders. With appropriate protocols, these psychoactive agents may become part of comprehensive therapy for mental disorders.